Amarin Corp Plcuk (AMRN) EBT (2010 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly EBT of -$8.7 million for Q1 2026, up 36.0% YoY from -$6.4 million in Q1 2025, and down 923.83% sequentially from -$852000.0 in Q4 2025.
Amarin Corp Plcuk (AMRN) EBT (2010 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed EBT across 17 years of filings, most recently posting -$8.7 million for Q1 2026.
- In Q1 2026, EBT rose 36.0% year-over-year to -$8.7 million; the TTM figure through Mar 2026 stood at -$31.1 million (down 203.57% YoY), while the FY2025 annual figure was -$36.0 million, down 582.21% from the prior year.
- EBT eased to -$8.7 million in Q1 2026, from -$852000.0 in the prior quarter.
- Over the last five years, EBT for AMRN reached as high as $102.4 million in Q4 2022 and fell as low as -$64.8 million in Q2 2022.
- The 5-year median for EBT is -$8.7 million (2026), against an average of -$5.8 million.
- Annual changes were most pronounced in 2022 — EBT slumped 2729.34% — and 2024, when it jumped 998.69%.
- A 5-year view of EBT shows it stood at $102.4 million in 2022, then slumped by 102.39% to -$2.4 million in 2023, then jumped by 998.69% to $22.0 million in 2024, then plunged by 103.87% to -$852000.0 in 2025, then sank by 923.83% to -$8.7 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$8.7 million, -$852000.0, and -$8.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 8.85 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 5.99 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 1.04 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 3.91 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -3.50 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 2.08 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 2.58 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 3.17 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | -8.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.72 Mn |
| Dec 31, 2025 | -852,000.00 |
| Sep 30, 2025 | -8.12 Mn |
| Jun 30, 2025 | -13.45 Mn |
| Mar 31, 2025 | -13.63 Mn |
| Dec 31, 2024 | 22.01 Mn |
| Sep 30, 2024 | -21.53 Mn |
| Jun 30, 2024 | 2.89 Mn |
| Mar 31, 2024 | -8.66 Mn |
| Dec 31, 2023 | -2.45 Mn |
| Sep 30, 2023 | -18.81 Mn |
| Jun 30, 2023 | -17.92 Mn |
| Mar 31, 2023 | -14.50 Mn |
| Dec 31, 2022 | 102.39 Mn |
| Sep 30, 2022 | -3.88 Mn |
| Jun 30, 2022 | -64.80 Mn |
| Mar 31, 2022 | -28.35 Mn |
| Dec 31, 2021 | 16.39 Mn |
| Sep 30, 2021 | -12.97 Mn |
| Jun 30, 2021 | 8.87 Mn |